NURS FPX 9010 Assessment 3: Project Design and Methodology

Assessment Overview:

NURS FPX 9010 Assessment 3: emphasizes creating a robust, evidence-based framework for a DNP project. Students design a quasi-experimental or quality improvement intervention to address a clinical problem, in this case, low medication adherence in hypertensive adults. Key elements include clearly defined purpose and objectives, structured methodology, participant selection, intervention details, data collection and analysis, and ethical considerations. The design must be feasible, rigorous, and provide a foundation for subsequent implementation and evaluation phases.High-quality submissions demonstrate methodological rigor, ethical integrity, clear alignment with objectives, and readiness for implementation in a clinical setting.

Key Objectives

Understanding the Requirements

Criteria

Distinguished

Proficient

Complete Assessment Outline

Introduction

• Introduce the clinical issue or topic
• Explain its relevance to nursing practice
• State the purpose of the assessment

Research Process

• Describe databases and search strategies used
• Explain criteria for selecting credible sources
• Discuss evaluation of source quality and relevance

Evidence Synthesis

• Summarize key findings from research sources
• Compare and contrast different perspectives
• Identify patterns and themes in the evidence

Application to Practice

• Explain how research informs clinical decisions
• Provide specific examples of practice applications
• Discuss implications for patient outcomes

Conclusion

• Summarize key points and findings
• Reinforce the importance of evidence-based practice
• Suggest areas for future research or practice improvement

How to Pass NURS FPX 9010 Assessment 3: Project Design and Methodology

  • Understand the Purpose – Focus on designing a doable, substantiation-grounded DNP design to address a clinical problem (e.g., low drug adherence). 
  • Define Clear objectives – State measurable intentions like perfecting drug adherence, blood pressure control, or patient engagement. 
  • Choose the Right Study Design – Use quasi-experimental, retest-posttest, or quality enhancement designs; explain why it fits your design. 
  • Describe the Setting & Population – Include clinic details, party criteria (age, opinion, and digital access), and sample size. 
  • Detail the Intervention—Specify who delivers it, what’s done, when, where, and how, including education, digital tools, and follow-up. 
  • Plan Data Collection – Use validated tools like MMAS-8 for adherence, BP readings, and voluntary patient interviews for qualitative feedback. 
  • Specify Data Analysis styles – Include descriptive statistics, paired t-tests for quantitative data, and thematic analysis for qualitative data. 
  • Include Ethical Considerations—Describe IRB blessing, informed consent, confidentiality, voluntary participation, and threat minimization. 
  • Figure Evaluation Plan – Define primary and secondary issues, feasibility, and sustainability measures. 
  • Prepare for the coming way—ensure your design provides a clear foundation for Assessment 4, where you apply and estimate the design. 

Sample Assessment Paper

Introduction

A well-structured design ensures the rigor, validity, and feasibility of a Doctor of Nursing Practice (DNP) design. This paper presents the design and methodology for a DNP design addressing low drug adherence among hypertensive grown-ups in primary care. The design proposes administering a nanny-led digital adherence program that integrates mobile reminders, education, and follow-up to ameliorate adherence and blood pressure control. The design includes population, setting, intervention, data collection, evaluation, and ethical considerations. 

Project Purpose and Objectives

The purpose of this DNP design is to ameliorate drug adherence among grown-ups diagnosed with hypertension through a structured nanny-led digital health intervention. 

Objectives:

  1. Increase drug adherence by 25 within 12 weeks. 
  2. ameliorate average blood pressure control among actors. 
  3. Enhance patient engagement and tone-operation chops. 
  4. Estimate the feasibility and adequacy of the digital adherence program. 

Project Design

This design will use a quasi-experimental retest-posttest design to estimate changes in adherence and blood pressure before and after performance. 

Rationale:
A quasi-experimental design allows practical evaluation in a real-world clinical terrain where randomization is not doable. This design supports outgrowth comparison over time and measures the effectiveness of interventions in clinical practice.

NURS FPX 9010 Assessment 3: Setting and Population

Setting:
The design will take place in a primary care clinic combined with a large healthcare system serving roughly 3,000 adult cases annually. 

Population:

  • grown—aged 30–75 diagnosed with hypertension. 
  • specified at least one antihypertensive drug. 
  • Own a smartphone and can operate introductory digital operations. 
  • Rejection of cognitive impairment or severe comorbidities. 

Sample Size:
A convenience sample of 30 actors will be signed. This size is respectable for an airman designed to assess feasibility and effect size. 

Intervention Description

  • The nanny-led digital adherence program includes 
  • original assessment of birth adherence, blood pressure, and demographic data. 
  • Education Session A 20-nanosecond substantiated session on hypertension operation and drug significance. 
  • Mobile Reminders Daily drug monitoring using a secure app. 
  • Follow-up calls: quotidian 10-nanosecond nanny calls for provocation, troubleshooting, and underpinning. 
  • Post-Intervention Evaluation Adherence and blood pressure reassessment at 12 weeks. 

The intervention aligns with validation from former studies (Chen et al., 2022; Johnson et al., 2022) showing advanced adherence and case satisfaction through nurse-led and digital approaches. 

Data Collection Methods

Quantitative Data:

  • Drug adherence measured using the Morisky Medication Adherence Scale (MMAS-8). 
  • Blood pressure measured using a calibrated automatic sphygmomanometer at birth and week 12. 
  • Engagement data collected from app operation logs. 

Qualitative Data (Optional):
Short post-intervention interviews will explore party satisfaction and barriers to adherence. 

Data Analysis Plan

  • Quantitative paired t-tests will compare pre- and post-intervention adherence and blood pressure. Descriptive statistics (mean, SD, and chances) will epitomize demographics and adherence rates. 
  • Qualitative thematic analysis will be used to identify patterns from interview responses. 
  • Software IBM SPSS Statistics (Version 29) will be used for quantitative analysis. 

Ethical Considerations

  • Institutional Review Board (IRB) blessing will be attained first for performance. 
  • Informed concurrence will be secured from all actors. 
  • Data will be de-linked to ensure sequestration and confidentiality. 
  • Actors can withdraw at any time without penalty. 
  • The study poses minimum trouble, primarily related to data sequestration. 

Evaluation Plan

Primary Outcome:

  • Increase in MMAS-8 adherence scores. 

Secondary Outcomes:

  • Reduction in mean systolic/diastolic blood pressure. 
  • party satisfaction (check-predicated). 

Evaluation will concentrate on effectiveness, feasibility, and sustainability within the primary care terrain. 

Expected Outcomes

  • Advanced drug adherence rates (> 25). 
  • drop in average systolic BP by 10 mmHg. 
  • Positive party feedback regarding the usability and helpfulness of the digital tool. 
  • Increased nanny engagement in case-centered technology interventions. 

Conclusion

The proposed nanny-led digital adherence program provides a structured, confirmation-tested frame for addressing drug nonadherence in hypertensive cases. By integrating technology, education, and follow-up, this DNP design promotes platoon operation and sustainable health enhancement. The methodology ensures rigor, ethical integrity, and practical connection—laying a strong foundation for performance and evaluation in future assessments.

References

  • Basu, S., Patel, R., & Kim, M. (2021). Behavioral strategies to improve medicine adherence in cases with hypertension: A regular review. Journal of Cardiovascular Nursing, 36(4), 321–329. https://doi.org/10.1097/JCN.0000000000000756
  • Bosworth, H. B., Olsen, M. K., & Granger, B. B. (2021). medicine adherence A call for bettered measures to align with the patient experience. American Heart Journal, 240, 34–40. https://doi.org/10.1016/j.ahj.2021.06.006
  • Chen, Y., Li, J., & Wang, Z. (2022). Effectiveness of mobile-predicated interventions on medicine adherence in cases with hypertension: A meta-analysis. Journal of Hypertension, 40(6), 1248–1257. https://doi.org/10.1097/HJH.0000000000003098
  • Johnson, R. L., Evans, P., & Clark, J. (2022). Team-predicted interventions to improve medicine adherence among hypertensive grown-ups. Primary Care Nursing Journal, 29(2), 145–153. 
  • Li, X., Zhou, Q., & Zhang, H. (2023). The role of mobile health in managing hypertension: integrating technology into nursing practice. Digital Health Nursing, 7(1), 12–20. 

Rubric Breakdown

Criteria Exemplary (4) Proficient (3) Developing (2) Needs Improvement (1)
Purpose & Objectives Clear, measurable, aligned with clinical problems and DNP essentials. Mostly clear; minor detail gaps. Objectives somewhat vague or partially aligned. Objectives unclear or missing.
Design & Methodology Methodology fully described, justified, and feasible. Methodology mostly described; minor justification gaps. Methodology partially described; justification weak. Methodology unclear or missing.
Setting & Population Population, inclusion/exclusion criteria, sample size, and setting clearly defined. Mostly complete; minor missing details. Limited population or setting description. Population/setting unclear or incomplete.
Intervention Description Intervention details complete (who, what, when, where, how); evidence-based. Mostly complete; minor gaps. Partially described; limited detail. Intervention unclear or missing.
Data Collection & Analysis Quantitative and optional qualitative methods fully described; analysis appropriate. Mostly complete; minor gaps. Limited description; analysis unclear. Methods/analysis missing or inappropriate.
Ethical Considerations IRB, consent, confidentiality, and risk minimization fully addressed. Most ethical aspects covered; minor gaps. Limited ethical description. Ethical considerations missing or inadequate.
Evaluation & Expected Outcomes Clear primary/secondary outcomes, feasibility, and sustainability addressed. Mostly clear; minor detail gaps. Limited outcome description. Outcomes unclear or missing.
Organization & Clarity Well-organized, logical flow, professional writing. Mostly organized; minor clarity issues. Some organization issues; hard to follow. Disorganized; unclear or unprofessional.

 

Step-by-Step Guide

  1. Purpose & objects – Ameliorate drug adherence and blood pressure control in grown-ups with hypertension using a nanny-led digital intervention; objects include a ≥ 25% adherence increase, BP reduction, enhanced patient engagement, and feasibility assessment. 
  2. Design Selection – A quasi-experimental retest-posttest design was chosen for real-world connection and comparison of issues over time. 
  3. Setting – Primary care clinic within a large healthcare system serving grown-up cases annually. 
  4. Population & Sample – Grown-ups aged 30 – 75 with hypertension, specified at least one antihypertensive, and smartphone users; convenience sample of 30 actors. 
  5. Intervention factors – original assessment, 20-nanosecond nanny-led education session, diurnal mobile monuments, diurnal nanny follow-up calls, and 12-week post-intervention evaluation. 
  6. Data Collection – Quantitative MMAS-8 for adherence, automated BP readings, app engagement logs; qualitative (voluntary) brief interviews on satisfaction and walls. 
  7. Data Analysis – Paired t-tests for pre/post quantitative issues; descriptive statistics for demographics; thematic analysis for qualitative feedback; IBM SPSS Version 29 used. 
  8. Ethical Considerations – IRB blessing, informed consent, confidentiality, voluntary participation, and minimum threat assured. 
  9. Evaluation Plan – Primary outgrowth adherence enhancement; secondary issues: BP reduction and case satisfaction; concentrate on feasibility and sustainability. 
  10. Anticipated issues – Increased adherence (> 25), systolic BP drop
  11. 10 mmHg), positive case feedback, and strengthened nanny engagement in digital interventions.

Frequently Asked Questions (FAQ's)

1. What type of design should I use? 

Most DNP systems use quasi-experimental or quality enhancement (QI) designs rather than randomized trials. 

2. How detailed should my intervention be? 

Include who, what, when, where, and how—the clearer the performance plan, the better. 

3. Do I need IRB blessing at this stage? 

You don’t need formal IRB blessing yet, but you must describe how you’ll gain it before performance. 

4. How long should my design last? 

Birdman DNP systems constantly gauge 8–12 weeks, depending on feasibility and setting. 

5. Should I include both qualitative and quantitative data? 

You can—mixed-style designs supply richer evaluation, though quantitative-only is consistently sufficient. 

6. What’s the paper length? 

generally 6–8 runners, banning references and supplements. 

7. What’s next after Assessment 3? 

In NURS FPX 9010 Assessment 4, you’ll develop the design performance and evaluation plan based on this design. 

NURS FPX 9010 Assessment 3

What You'll Get

Instant access • No credit card

You cannot copy content of this page

Get Instant Access to Sample Paper

Fill out the form below.